Marfan syndrome: What internists and pediatric or adult cardiologists need to know

Expert Review of Cardiovascular Therapy

Volumn 3, Issue 5, 2005, Pages 891-909

  Kaemmerer, Harald ^a   Oechslin, Erwin ^b   Seidel, Heide ^c   Neuhann, Thomas ^d   Neuhann, Irmingard Maria ^e   Mayer, H Michael ^f   Hess, John ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF MUNICH   (Germany)

^d Red Cross Hospital   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f Spine Centre Munich   (Germany)

Author keywords

Aortic aneurysm; Aortic dissection; Fibrillin; Genetic disorder; Lens dislocation; Marfan syndrome; Mitral valve prolapse; Scoliosis

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; FIBRILLIN 1; NITROPRUSSIDE SODIUM; PROGESTERONE; VERAPAMIL;

ADULT; AORTA DISEASE; AORTA DISSECTION; AORTA WALL; AUTOSOMAL DOMINANT INHERITANCE; BACTEREMIA; BONE DISEASE; CARDIOLOGY; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHONDROPATHY; CHROMOSOME 15Q; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DEATH; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EYE DISEASE; FAMILY HISTORY; FOLLOW UP; GENE FREQUENCY; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENETIC CODE; GENETIC COUNSELING; HEALTH PRACTITIONER; HUMAN; INTERNAL MEDICINE; LIGAMENT DISEASE; LUNG DISEASE; MARFAN SYNDROME; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT MONITORING; PEDIATRICS; PLEIOTROPY; PRACTICE GUIDELINE; PROGNOSIS; PROTEIN STRUCTURE; REVIEW; SCOLIOSIS; SKIN DISEASE; SOCIAL PSYCHOLOGY; SPINE DISEASE; TENDON DISEASE; TREATMENT PLANNING; VALVULAR HEART DISEASE; VASCULAR DISEASE;

EID: 26844494093     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.3.5.891     Document Type: Review

References (129)

1. Milewicz DM, Dietz HC, Miller DC. Treatment of aortic disease in patients with Marfan syndrome. Circulation 111(11), e150-e157 (2005).
2. Webb G, David TE. Marfan syndrome: a cardiovascular perspective. In: Diagnosis and Management of Adult Congenital Heart Disease. MA Gatzoulis, GD Webb, PEF Daubeney (Eds). Churchill Livingstone, London, UK (2003).
3. Marfan AB. Un cas de deformation congenitale des quatre membres plus prononcee aux extremites caracterisee par l'allongement des os avec un certain degre d'amincissement. Bull. Mem. Soc. Med. Hop. Paris 13, 220-226 (1896).
4. Baer RW, Taussig HB, Oppenheimer EH. Congenital aneurysmal dilatation of the aorta associated with arachnodactyly. Bull. Johns Hopkins Hosp. 72, 309-331 (1943).
5. Etter LE, Glover LP. Arachnodactyly complicated by dislocated lens and death from rupture of dissecting aneurysm of aorta. JAMA 123, 88-89 (1943).
6. McKusick V. The cardiovascular aspects of Marfan's syndrome: a heritable disorder of connective tissue. Circulation (3), 321-342 (1955).
7. Pyeritz RE. The Marfan syndrome. Annu. Rev. Med. 51, 481-510 (2000).
8. Dietz HC, Cutting GR, Pyeritz RE et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352(6333), 337-339 (1991).
9. Shores J, Berger KR, Murphy EA et al. Progression of aortic dilatation and the benefit of long-term β-adrenergic blockade in Marfan's syndrome. N. Engl. J. Med. 330(19), 1335-1341 (1994).
10. Svensson LG, Crawford ES, Coselli JS et al. Impact of cardiovascular operation on survival in the Marfan patient. Circulation 80(3 Pt. 1), I233-I242 (1989).
11. Gott VL, Cameron DE, Pyeritz RE et al. Composite graft repair of Marfan aneurysm of the ascending aorta: results in 150 patients. J. Card. Surg. 9(5), 482-489 (1994).
12. Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J. Cell Biol. 103(6 Pt. 1), 2499-2509 (1986).
13. Pereira L, D'Alessio M, Ramirez F et al. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum. Mol. Genet. 2(10), 1762 (1993).
14. Mizuguchi T, Collod-Beroud G, Akiyama T et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nature Genet. 36(8), 855-860 (2004).
15. Collod-Beroud G, Beroud C, Ades L et al. Marfan Database (third edition): new mutations and new routines for the software. Nucleic Acids Res. 26(1), 229-223 (1998).
16. Putnam EA, Cho M, Zinn AB et al. Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1. Am. J. Med. Genet. 62, 233-242 (1996).
17. von Kodolitsch Y, Raghunath M, Nienaber CA. Marfan syndrome: prevalence and natural course of cardiovascular manifestations. Z. Kardiol. 87(3), 150-460 (1998).
18. Pyeritz RE, Marfan syndrome: current and future clinical and genetic management of cardiovascular manifestations. Semin. Thorac. Cardiovasc. Surg. 5(1), 11-46 (1993).
19. Marlow N, Gregg JE, SA Q. Mitral valve disease in Marfan's syndrome. Arch. Dis. Child. 62, 960-962 (1987).
20. Morse RP, Rockenmacher S, Pyeritz RE et al. Diagnosis and management of infantile marfan syndrome. Pediatrics 86, 888-895 (1990).
21. Murdoch JL, Walker BA, Halpern BL et al. Life expectancy and causes of death in the Marfan syndrome. N. Engl. J. Med. 286(15), 804-808 (1972).
22. Finkbohner R, Johnston D, Crawford ES et al. Marfan syndrome. Long-term survival and complications after aortic aneurysm repair. Circulation 91(3), 728-733 (1995).
23. Silverman DI, Burton KJ, Gray J et al. Life expectancy in the Marfan syndrome. Am. J. Cardiol. 75(2), 157-160 (1995).
24. Gott VL, Greene PS, Alejo DE et al. Replacement of the aortic root in patients with Marfan's syndrome. N. Engl. J. Med. 340(17), 1307-1313 (1999).
25. Beighton P, de Paepe A, Danks D et al. International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am. J. Med. Genet. 29(3), 581-594 (1988).
26. De Paepe A, Devereux RB, Dietz HC et al. Revised diagnostic criteria for the Marfan syndrome. Am. J. Med. Genet. 62(4), 417-426 (1996).
27. Hobbs WR, Sponseller PD, Weiss AP et al. The cervical spine in Marfan syndrome. Spine 22(9), 983-989 (1997).
28. Sponseller PD, Tomek IM, Pyertiz RE. Developmental dysplasia of the hip in Marfan syndrome. J. Pediatr. Orthop. B. 6(4), 255-259 (1997).
29. Putnam EA, Zhang H, Ramirez F et al. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nature Genet. 11(4), 456-458 (1995).
30. Hamod A, Moodie D, Clark B et al. Presenting signs and clinical diagnosis in individuals referred to rule out Marfan syndrome. Ophthalmic Genet. 24(1), 35-39 (2003).
31. Izquierdo NJ, Traboulsi EI, Enger C et al. Strabismus in the Marfan syndrome. Am. J. Ophthalmol. 117(5), 632-635 (1994).
32. Roman MJ, Devereux RB, Kramer-Fox R et al. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am. J. Cardiol. 64(8), 507-512 (1989).
33. Legget ME, Unger TA, O'Sullivan CK et al. Aortic root complications in Marfan's syndrome: identification of a lower risk group. Heart 75(4), 389-395 (1996).
34. Erbel R, Alfonso F, Boileau C et al. Diagnosis and management of aortic dissection. Eur. Heart J. 22(18), 1642-4681 (2001).
35. Hager A, Kaemmerer H, Rapp-Bernhardt U et al. Diameters of the thoracic aorta throughout life as measured with helical computed tomography. J. Thorac. Cardiovasc. Surg. 123(6), 1060-1066 (2002).
36. Reed CM, Richey PA, Pulliam DA et al. Aortic dimensions in tall men and women. Am. J. Cardiol. 71(7), 608-610 (1993).
37. Nuss D, Kelly RE Jr, Croitoru DP et al. A 10-year review of a minimally invasive technique for the correction of pectus excavatum. J. Pediatr. Surg. 33(4), 545-552 (1998).
38. Fredriks AM, van Buuren S, van Heel W et al. Nation-wide age references for sitting height, leg length and sitting height/height ratio and their diagnostic value for disproportionate growth disorders. Arch. Dis. Child (Epub ahead of print) (2005).
39. Cecconi M, Manfrin M, Moraca A et al. Aortic dimensions in patients with bicuspid aortic valve without significant valve dysfunction. Am. J. Cardiol. 95(2), 292-294 (2005).
40. Nollen GJ, van Schijndel KE, Timmermans J et al. Pulmonary artery root dilatation in Marfan syndrome: quantitative assessment of an unknown criterion. Heart 87(5), 470-471 (2002).
41. Meijboom LJ, Nollen GJ, Mulder BJM. Prevention of Cardiovascular Complications in the Marfan Syndrome. Vasc. Dis. Prev. 1, 79-86 (2004).
42. Roberts WC, Honig HS. The spectrum of cardiovascular disease in the Marfan syndrome: a clinico-morphologic study of 18 necropsy patients and comparison to 151 previously reported necropsy patients. Am. Heart J. 104(1), 115-135 (1982).
43. Groenink M, Lohuis TA, Tijssen JG et al. Survival and complication free survival in Marfan's syndrome: implications of current guidelines. Heart 82(4), 499-504 (1999).
44. Sutsch G, Jenni R, von Segesser L et al. Predictability of aortic dissection as a function of aortic diameter. Eur. Heart J. 12(12), 1247-1256 (1991).
45. Roman MJ, Rosen SE, Kramer-Fox R et al. Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome. J. Am. Coll. Cardiol. 22(5), 1470-1476 (1993).
46. Benjamin IJ. Matrix metalloproteinases: from biology to therapeutic strategies in cardiovascular disease. J. Investig. Med. 49(5), 381-397 (2001).
47. Goodall S, Crowther M, Hemingway DM et al. Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Circulation 104(3), 304-309 (2001).
48. Lima SD, Lima JA, Pyeritz RE et al. Relation of mitral valve prolapse to left ventricular size in Marfan's syndrome. Am. J. Cardiol. 55(6), 739-743 (1985).
49. Devereux RB, Kramer-Fox R, Kligfield P. Mitral valve prolapse: causes, clinical manifestations, and management. Ann. Intern. Med. 111(4), 305-317 (1989).
50. Pini R, Roman MJ, Kramer-Fox R et al. Mitral valve dimensions and motion in Marfan patients with and without mitral valve prolapse. Comparison to primary mitral valve prolapse and normal subjects. Circulation 80(4), 915-924 (1989).
51. van Karnebeek CD, Naeff MS, Mulder BJ et al. Natural history of cardiovascular manifestations in Marfan syndrome. Arch. Dis. Child. 84(2), 129-137 (2001).
52. von Kodolitsch Y RM. Cardiovascular aspects of the Marfan syndrome: A systemic review. In: Marfan Syndrome: A Primer for Clinicians and Scientists. Robinson PN, Godfrey M (Eds). Kluwer Academic, NL, USA. 45-69 (2005).
53. El Habbel MH. Cardiovascular manifestations of Marfan's syndrome in the young. Am. Heart J. 123, 752 (1992).
54. Niwa K, Perloff JK, Bhuta SM et al. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation 103(3), 393-400 (2001).
55. Becker AE, van Mantgem JP. The coronary arteries in Marfan's syndrome. A morphologic study. Am. J. Cardiol. 36(3), 315-321 (1975).
56. Gillinov AM, Hulyalkar A, Cameron DE et al. Mitral valve operation in patients with the Marfan syndrome. J. Thorac. Cardiovasc. Surg. 107(3), 724-731 (1994).
57. Porciani MC, Giurlani L, Chelucci A et al. Diastolic subclinical primary alterations in Marfan syndrome and Marfan-related disorders. Clin. Cardiol. 25(9), 416-420 (2002).
58. Chatrath R, Beauchesne LM, Connolly HM et al. Left ventricular function in the Marfan syndrome without significant valvular regurgitation. Am. J. Cardiol. 91(7), 914-916 (2003).
59. Savolainen A, Nisula L, Keto P et al. Left ventricular function in children with the Marfan syndrome. Eur. Heart J. 15(5), 625-630 (1994).
60. Yetman AT, Bornemeier RA, McCrindle BW. Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? J. Am. Coll. Cardiol. 41(2), 329-332 (2003).
61. Basso C, Frescura C, Corrado D et al. Congenital heart disease and sudden death in the young. Hum. Pathol. 26(10), 1065-1072 (1995).
62. Maron BJ, Shirani J, Poliac LC et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 276(3), 199-204 (1996).
63. Chen S, Fagan LF, Nouri S et al. Ventricular dysrhythmias in children with Marfan's syndrome. Am. J. Dis. Child. 139(3), 273-276 (1985).
64. Soman VR, Breton G, Hershkowitz M et al. Bacterial endocarditis of mitral valve in Marfan syndrome. Br. Heart J. 36(12), 1247-1250 (1974).
65. De Paepe A. Dural ectasia and the diagnosis of Marfan's syndrome. Lancet 11 354(9182), 878-879 (1999).
66. Fattori R, Nienaber CA, Descovich B et al. Importance of dural ectasia in phenotypic assessment of Marfan's syndrome. Lancet 354(9182), 910-913 (1999).
67. Oosterhof T, Groenink M, Hulsmans FJ et al. Quantitative assessment of dural ectasia as a marker for Marfan syndrome. Radiology 220(2), 514-518 (2001).
68. Ahn NU, Sponseller PD, Ahn UM et al. Dural ectasia in the Marfan syndrome: MR and CT findings and criteria. Genet. Med. 2(3), 173-179 (2000).
69. Habermann CR, Weiss F, Schoder V et al. MR evaluation of dural ectasia in Marfan syndrome: reassessment of the established criteria in children, adolescents, and young adults. Radiology 234(2), 535-541 (2005).
70. Ahn NU, Sponseller PD, Ahn UM et al. Dural ectasia is associated with back pain in Marfan syndrome. Spine 25(12), 1562-1568 (2000).
71. Kaemmerer H, Stern H, Fratz S et al. Imaging in adults with congenital cardiac disease (ACCD). Thorac. Cardiovasc. Surg. 48(6), 328-335 (2000).
72. von Kodolitsch Y, Raghunath M, Dieckmann C et al. Marfan syndrome: diagnosis of cardiovascular manifestations. Z. Kardiol. 87(3), 161-172 (1998).
73. Rigatelli G, Zanchetta M. Thoracic and abdominal aortic aneurysms: invasive and non-invasive imaging from an endovascular perspective. Ital. Heart J. 4(3), 205-210 (2003).
74. Hager A, Kaemmerer H, Leppert A et al. Follow-up of adults with coarctation of the aorta: comparison of helical CT and MRI, and impact on assessing diameter changes. Chest 126(4), 1169-1176 (2004).
75. Adams JN, Brooks M, Redpath TW et al. Aortic distensibility and stiffness index measured by magnetic resonance imaging in patients with Marfan's syndrome. Br. Heart J. 73(3), 265-269 (1995).
76. Groenink M, de Roos A, Mulder BJ et al. Biophysical properties of the normal-sized aorta in patients with Marfan syndrome: evaluation with MR flow mapping. Radiology 219(2), 535-540 (2001).
77. Hirata K, Triposkiadis F, Sparks E et al. The Marfan syndrome: abnormal aortic elastic properties. J. Am. Coll. Cardiol. 18(1), 57-63 (1991).
78. Fattori R, Bacchi Reggiani L, Pepe G et al. Magnetic resonance imaging evaluation of aortic elastic properties as early expression of Marfan syndrome. J. Cardiovasc. Magn. Reson. 2(4), 251-256 (2000).
79. Baumgartner D, Baumgartner C, Matyas G et al. Diagnostic power of aortic elastic properties in young patients with Marfan syndrome. J. Thorac. Cardiovasc. Surg. 129(4), 730-739 (2005).
80. von Kodolitsch Y, Raghunath M, Karck M et al. Marfan syndrome: therapy of cardiovascular manifestations. Z. Kardiol. 87(3), 173-184 (1998).
81. Salim MA, Albert BS, Ward JC, Pyeritz RE. Sports and Marfan syndrome. Awareness and early diagnosis can prevent sudden death. Phys. Sportsmed. 29, 1-10 (2001).
82. Braverman AC. Exercise and the Marfan syndrome. Med. Sci. Sports Exerc. 30(Suppl. 10), S387-S395 (1998).
83. Halpern BL, Char F, Murdoch JL et al. A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment. Johns Hopkins Med. J. 129(3), 123-129 (1971).
84. Rossi-Foulkes R, Roman MJ, Rosen SE et al. Phenotypic features and impact of β blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome. Am. J. Cardiol, 83(9), 1364-1368 (1999).
85. Haouzi A, Berglund H, Pelikan PC et al. Heterogeneous aortic response to acute β-adrenergic blockade in Marfan syndrome. Am. Heart J. 133(1), 60-63 (1997).
86. Yin FC, Brin KP, Ting CT et al. Arterial hemodynamic indexes in Marfan's syndrome. Circulation 79(4), 854-862 (1989).
87. Rios AS, Silber EN, Bavishi N et al. Effect of long-term β-blockade on aortic root compliance in patients with Marfan syndrome. Am. Heart J. 137(6), 1057-1061 (1999).
88. Groenink M, de Roos A, Mulder BJ et al. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following β-blocker therapy in the Marfan syndrome. Am. J. Cardiol. 82(2), 203-208 (1998).
89. Pyeritz RE. Maternal and fetal complications of pregnancy in the Marfan syndrome. Am. J. Med. (5), 784-790 (1981).
90. Yetman AT, Bornemeier RA, McCrindle BW. Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am. J. Cardiol. 95(9), 1125-1127 (2005).
91. Nagashima H, Sakomura Y, Aoka Y et al. Angiotensin II Type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome. Circulation 104(12 Suppl. 1), I282-I287 (2001).
92. Yetman AT, Huang P, Bornemeier RA et al. Comparison of outcome of the Marfan Syndrome in patients diagnosed at age < or = 6 years versus those diagnosed at > 6 years of age. Am. J. Cardiol. 91(1), 102-403 (2003).
93. Davies RR, Goldstein LJ, Coady MA et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann. Thorac. Surg. (1), 17-27 discussion 27-18 (2002).
94. Tambeur L, David TE, Unger M et al. Results of surgery for aortic root aneurysm in patients with the Marfan syndrome. Eur. J. Cardiothorac. Surg. 17(4), 415-419 (2000).
95. Therrien J, Gatzoulis M, Graham T et al. Canadian Cardiovascular Society Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease-Part II. Can. J. Cardiol. 17(10), 1029-1050 (2001).
96. Nienaber CA, Von Kodolitsch Y. Therapeutic management of patients with Marfan syndrome: focus on cardiovascular involvement. Cardiol. Rev. 7(6), 332-341 (1999).
97. Bentall H, De Bono A. A technique for complete replacement of the ascending aorta. Thorax 23(4), 338-339 (1968).
98. Gott VL, Cameron DE, Alejo DE et al. Aortic root replacement in 271 Marfan patients: a 24-year experience. Ann. Thorac. Surg. 73(2), 438-443 (2002).
99. Miller DC. Valve-sparing aortic root replacement in patients with the Marfan syndrome. J. Thorac. Cardiovasc. Surg. 125(4), 773-778 (2003).
100. Sarsam MA, Yacoub M. Remodeling of the aortic valve anulus. J. Thorac. Cardiovasc. Surg. 105(3), 435-438 (1993).
101. David TE, Feindel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J. Thorac. Cardiovasc. Surg. 103(4), 617-621 (1992).
102. David TE. Current practice in Marfan's aortic root surgery: reconstruction with aortic valve preservation or replacement? What to do with the mitral valve? J. Card. Surg. 12(Suppl. 2), 147-150 (1997).
103. Birks EJ, Webb C, Child A et al. Early and long-term results of a valve-sparing operation for Marfan syndrome. Circulation 100(Suppl. 19), II29-II35 (1999).
104. de Oliveira NC, David TE, Ivanov J et al. Results of surgery for aortic root aneurysm in patients with Marfan syndrome. J. Thorac. Cardiovasc. Surg. 125(4), 789-796 (2003).
105. Nienaber CA, Fattori R, Lund G et al. Nonsurgical reconstruction of thoracic aortic dissection by stent-graft placement. N. Engl. J. Med. 340(20), 1539-1545 (1999).
106. Fleck TM, Hutschala D, Tschernich H et al. Stent graft placement of the thoracoabdominal aorta in a patient with Marfan syndrome. J. Thorac. Cardiovasc. Surg. 125(6), 1541-1543 (2003).
107. Sisk HE, Zahka KG, Pyeritz RE. The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age. Am. J. Cardiol. 52(3), 353-358 (1983).
108. Tsang VT, Pawade A, Karl TR et al. Surgical management of Marfan syndrome in children. J. Card. Surg. 9(1), 50-54 (1994).
109. Scherer LR, Arn PH, Dressel DA et al. Surgical management of children and young adults with Marfan syndrome and pectus excavatum. J. Pediatr. Surg. 23(12), 1169-1172 (1988).
110. Arn PH, Scherer LR, Haller JA Jr et al. Outcome of pectus excavatum in patients with Marfan syndrome and in the general population. J. Pediatr. 115(6), 954-958 (1989).
111. Sponseller PD, Hobbs W, Riley LH III et al. The thoracolumbar spine in Marfan syndrome. J. Bone Joint Surg. Am. 77(6), 867-876 (1995).
112. Lenke LG, Edwards CC II, Bridwell KH. The Lenke classification of adolescent idiopathic scoliosis: how it organizes curve patterns as a template to perform selective fusions of the spine. Spine 28(20), S199-S207 (2003).
113. Faro FD, Marks MC, Newton PO et al. Perioperative changes in pulmonary function after anterior scoliosis instrumentation: thoracoscopic versus open approaches. Spine 30(9), 1058-4063 (2005).
114. Lenke LG, Newton PO, Marks MC et al. Prospective pulmonary function comparison of open versus endoscopic anterior fusion combined with posterior fusion in adolescent idiopathic scoliosis. Spine 29(18), 2055-2060 (2004).
115. Kuhlman JE, Scott WW Jr, Fishman EK et al. Acetabular protrusion in the Marfan syndrome. Radiology 164(2), 415-417 (1987).
116. Hall JR, Pyeritz RE, Dudgeon DL et al. Pneumothorax in the Marfan syndrome: prevalence and therapy. Ann. Thorac. Surg. 37(6), 500-504 (1984).
117. Loewenstein A, Barequet IS, De Juan E Jr et al. Retinal detachment in Marfan syndrome. Retina 20(4), 358-363 (2000).
118. Sharma T, Gopal L, Shanmugam MP et al. Retinal detachment in Marfan syndrome: clinical characteristics and surgical outcome. Retina 22(4), 423-428 (2002).
119. Van Tongerloo A, De Paepe A. Psychosocial adaptation in adolescents and young adults with Marfan syndrome: an exploratory study. J. Med. Genet. 35(5), 405-409 (1998).
120. Elkayam U, Ostrzega E, Shotan A et al. Cardiovascular problems in pregnant women with the Marfan syndrome. Ann. Intern. Med. 123(2), 117-122 (1995).
121. Meijboorn LJ, Vos FE, Timmermans J et al. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur. Heart J. 26(9), 914-920 (2005).
122. Brice G, Treasure T, Pumphrey C, Leech G, Child A. Serial echocardiography is of limited value in predicting aortic dissection in pregnant Marfan patients. Eur J. Pediatr. 155, 745-746 (1996).
123. Lipscomb KJ, Smith JC, Clarke B et al. Outcome of pregnancy in women with Marfan's syndrome. Br. J. Obstet. Gynaecol. 104(2), 201-206 (1997).
124. Rossiter JP, Repke JT, Morales AJ et al. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am. J. Obstet. Gynecol. 173(5), 1599-1606 (1995).
125. Immer FF, Bansi AG, Immer-Bansi AS et al. Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann. Thorac. Surg. 76(1), 309-314 (2003).
126. Kawamoto S, Bluemke DA, Traill TA et al. Thoracoabdominal aorta in Marfan syndrome: MR imaging findings of progression of vasculopathy after surgical repair. Radiology 203(3), 727-732 (1997).
127. Meijboom LJ, Nollen GJ, Merchant N et al. Frequency of coronary ostial aneurysms after aortic root surgery in patients with the Marfan syndrome. Am. J. Cardiol. 89(9), 1135-1138 (2002).
128. von Kodolitsch Y, Raghunath M, Nienaber CA. Marfan syndrome: strategies of interdisciplinary care. Dtsch. Med. Wochenschr. 123(1-2), 21-25 (1998).
129. Kim SY, Martin N, Hsia EC et al. Management of aortic disease in Marfan Syndrome: a decision analysis. Arch. Intern. Med. 165(7), 749-755 (2005).